169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

Bibliographic Details
Main Authors:	Jeffrey Miller, Tom Lee, Ryan Bjordahl, Frank Cichocki, Jianfang Ning, Zachary Davis, Katie Tuininga, Hongbo Wang, Paul Rogers, Moyar Ge, Bob Valamehr, Clark Chen
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma
by: Jeffrey Miller, et al.
Published: (2020-11-01)

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
by: John B Sunwoo, et al.
Published: (2022-05-01)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Published: (2022-09-01)

1206 Immunometabolic modulation of engineered iPSC-NK cells for immunotherapy of solid tumors
by: Sandro Matosevic, et al.
Published: (2023-11-01)

Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity
by: Charlotte Flahou, et al.
Published: (2021-04-01)

iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors
by: Margarita E. Bogomiakova, et al.
Published: (2023-04-01)

iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
by: Kate J. Dixon, et al.
Published: (2024-07-01)

Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK Cells
by: Janine Melsen, et al.
Published: (2020-12-01)

114 Preclinical development of a novel iPSC-derived CAR-MICA/B NK cell immunotherapy to overcome solid tumor escape from NKG2D-mediated mechanisms of recognition and killing
by: Tom Lee, et al.
Published: (2020-11-01)

synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
by: Kyle B. Lupo, et al.
Published: (2024-03-01)

Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settings
by: Kyoko Masuda, et al.
Published: (2021-01-01)

High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
by: Seiji Nagano, et al.
Published: (2020-03-01)

418 The development of ‘off-the-shelf’ manufacturing strategies of iPSC-based gamma-delta T cells
by: Yanjie Li, et al.
Published: (2023-11-01)

Phenotypic and transcriptomic profiling of induced pluripotent stem cell (iPSC)-derived NK cells and their cytotoxicity against cancers
by: Nontaphat Thongsin, et al.
Published: (2024-11-01)

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy
by: Minggang Fang, et al.
Published: (2024-08-01)

In vitro Differentiation of Human iPSC-derived Cardiovascular Progenitor Cells (iPSC-CVPCs)
by: Agnieszka D’Antonio-Chronowska, et al.
Published: (2020-09-01)

120 Chemokine receptor engineering enhances trafficking and homing of primary and iPSC-derived CAR-T cells to solid tumors
by: Tom Lee, et al.
Published: (2021-11-01)

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
by: Jeffrey S Miller, et al.
Published: (2023-12-01)

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders
by: Lizhao Feng, et al.
Published: (2023-08-01)

In vitro Differentiation of Human iPSC-derived Retinal Pigment Epithelium Cells (iPSC-RPE)
by: Agnieszka D’Antonio-Chronowska, et al.
Published: (2019-12-01)

Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
by: Frank Cichocki, et al.
Published: (2022-11-01)

427 Development of iPSC-derived cytotoxic CD8+ T-cells as the basis for innovative off-the-shelf cancer immunotherapies
by: Daniel Sommermeyer, et al.
Published: (2023-11-01)

Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing
by: Yoshiki Furukawa, et al.
Published: (2022-01-01)

Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities
by: Matthias Huyghe, et al.
Published: (2024-10-01)

iPSC-derived cells for whole liver bioengineering
by: Kayque Alves Telles-Silva, et al.
Published: (2024-02-01)

iPSCs in NK Cell Manufacturing and NKEV Development
by: Nicholas Boyd-Gibbins, et al.
Published: (2022-07-01)

Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells
by: Fanyi Meng, et al.
Published: (2023-06-01)

Modeling Alzheimer’s disease with iPSC-derived brain cells
by: Penney, Jay, et al.
Published: (2020)

Robust detection of undifferentiated iPSC among differentiated cells
by: Keisuke Sekine, et al.
Published: (2020-06-01)

iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation
by: Kara Quaid, et al.
Published: (2025-02-01)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

380 Preliminary results of an ongoing phase I trial of FT500, a first-in-class, off-the-shelf, induced pluripotent stem cell (iPSC) derived natural killer (NK) cell therapy in advanced solid tumors
by: Sarah Cooley, et al.
Published: (2020-11-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

311 Disruption of TGF-b signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells
by: Jaya Lakshmi Thangaraj, et al.
Published: (2023-11-01)

Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D
by: John J. Jamieson, et al.
Published: (2019-06-01)

950 Epigenetic reprogramming of iPSC-derived T cells for CAR T cell therapy
by: Marcela Maus, et al.
Published: (2023-11-01)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
by: Erica L. Heipertz, et al.
Published: (2021-12-01)

Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line
by: Satoshi Matsui, et al.
Published: (2019-03-01)

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01)

iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
by: Benjamin H. Goldenson, et al.
Published: (2022-02-01)